More Life Company (TMLCF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 111 214 sessions, October 31, 2025 to November 2, 2026
- Largest daily move
- +94.8% close of March 20, 2026
- 1-year change
- +171.7% closing prices, October 31, 2025 to November 2, 2026
- 1-month change
- -18.2% closing prices, October 2, 2026 to November 2, 2026
Company Description
More Life Company (OTC: TMLCF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $15.8M.
TMLCF has gained 171.7% over the past year. The last closing price was $0.0345.
This page collects what Stock Titan holds for TMLCF, including price data, latest news, and short interest trends.
Stock Performance
More Life Company (TMLCF) closed at $0.0345 on November 2, 2026. Over the past 12 months, the price has gained 171.7%.
TMLCF Metrics & Rankings
Price returns through November 2, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
More Life Company has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. View all TMLCF news →
SEC Filings
Short Interest History
Short interest in More Life Company (TMLCF) currently stands at 40.7 thousand shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since August 2026, short interest has increased by 224.4%.
Days to Cover History
Days to cover for More Life Company (TMLCF) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
TMLCF Company Profile & Sector Positioning
More Life Company (TMLCF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing TMLCF often look at related companies in the same sector, including Healthy Extracts Inc (HYEX), Rubicon Organics Inc (ROMJF), Orexo AB (ORXOF), MariMed Inc (MRMD), and MediPharm Labs Corp (MEDIF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TMLCF's relative position within its industry.